Researchers at the University of Texas Health Science Center at San Antonio found a type of cellular stress in Alzheimer’s disease for the first time that is involved in cancer and aging.

Bristol-Myers Squibb Co. said it would license two of its drugs to Biogen Inc. and Roche Holding AG for an upfront fee of $470 million.